Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort study

Objectives: To describe comorbid conditions in patients with rheumatoid arthritis–associated interstitial lung disease (RA-ILD) and to analyze factors associated with multimorbidity. Methods: Nested case-cohort study of 2 prospective cohorts: one with RA-ILD (cases) and another with RA but not ILD (...

Full description

Bibliographic Details
Main Authors: Natalia Mena-Vázquez, Marta Rojas-Gimenez, Carmen María Romero-Barco, Myriam Gandía-Martínez, Nair Perez-Gómez, Francisco Javier Godoy-Navarrete, Sara Manrique-Arija, Aimara Garcia-Studer, Jerusalem Calvo-Gutiérrez, Clara Fuego Varela, Pilar Morales-Garrido, Patricia Castro Pérez, Coral Mouriño-Rodriguez, Isabel Añón-Oñate, Francisco Espildora, María Carmen Aguilar-Hurtado, Rocío Redondo, Ana Hidalgo Conde, Rocío Arnedo Díez de los Ríos, Eva Cabrera César, Maria Luisa Velloso-Feijoo, Antonio Fernández-Nebro
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S075333222201438X
_version_ 1811178928382935040
author Natalia Mena-Vázquez
Marta Rojas-Gimenez
Carmen María Romero-Barco
Myriam Gandía-Martínez
Nair Perez-Gómez
Francisco Javier Godoy-Navarrete
Sara Manrique-Arija
Aimara Garcia-Studer
Jerusalem Calvo-Gutiérrez
Clara Fuego Varela
Pilar Morales-Garrido
Patricia Castro Pérez
Coral Mouriño-Rodriguez
Isabel Añón-Oñate
Francisco Espildora
María Carmen Aguilar-Hurtado
Rocío Redondo
Ana Hidalgo Conde
Rocío Arnedo Díez de los Ríos
Eva Cabrera César
Maria Luisa Velloso-Feijoo
Antonio Fernández-Nebro
author_facet Natalia Mena-Vázquez
Marta Rojas-Gimenez
Carmen María Romero-Barco
Myriam Gandía-Martínez
Nair Perez-Gómez
Francisco Javier Godoy-Navarrete
Sara Manrique-Arija
Aimara Garcia-Studer
Jerusalem Calvo-Gutiérrez
Clara Fuego Varela
Pilar Morales-Garrido
Patricia Castro Pérez
Coral Mouriño-Rodriguez
Isabel Añón-Oñate
Francisco Espildora
María Carmen Aguilar-Hurtado
Rocío Redondo
Ana Hidalgo Conde
Rocío Arnedo Díez de los Ríos
Eva Cabrera César
Maria Luisa Velloso-Feijoo
Antonio Fernández-Nebro
author_sort Natalia Mena-Vázquez
collection DOAJ
description Objectives: To describe comorbid conditions in patients with rheumatoid arthritis–associated interstitial lung disease (RA-ILD) and to analyze factors associated with multimorbidity. Methods: Nested case-cohort study of 2 prospective cohorts: one with RA-ILD (cases) and another with RA but not ILD (controls). The cohorts were matched for age, sex, and time since diagnosis. Multimorbidity was defined as the co-occurrence of 2 or more chronic diseases, in addition to RA and ILD. We evaluated the comorbid conditions included in the Charlson Comorbidity Index, cardiovascular risk factors, neuropsychiatric conditions, and other frequent conditions in RA. We also recorded clinical-laboratory variables, inflammatory activity according to the 28-joint Disease Activity Score, C-reactive protein (CRP), physical function, and pulmonary function. We performed 2 multivariate analyses to identify factors associated with multimorbidity in RA and RA-ILD. Results: The final study population comprised 110 cases and 104 controls. Multimorbidity was more frequent among cases than controls (80 [72.7] vs 60 [57.7]; p = 0.021). In both groups, multimorbidity was associated with ILD (OR [95% CI] 1.92 [1.03–3.59]; p = 0.039), age (OR [95% CI] 1.05 [1.01–1.08]; p = 0.004), CRP (OR [95% CI] 1.16 [1.05–1.29]; p = 0.003), and erosions (OR [95% CI] 1.05 [1.01–1.08]; p = 0.004); in the cases, it was associated with CRP (OR [95% CI] 1.17 [1.01–1.35]; p = 0.027), anti–citrullinated peptide antibody (OR [95% CI] 1.23 [1.14–13.02]; p = 0.049), and forced vital capacity (OR [95% CI] 0.79 [0.96–0.99]; p = 0.036). Conclusion: In patients with RA, multimorbidity was associated with ILD, systemic inflammation, and advanced age.
first_indexed 2024-04-11T06:26:14Z
format Article
id doaj.art-5b210f3fc3134ae4993990e51792405c
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-04-11T06:26:14Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-5b210f3fc3134ae4993990e51792405c2022-12-22T04:40:21ZengElsevierBiomedicine & Pharmacotherapy0753-33222023-01-01157114049Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort studyNatalia Mena-Vázquez0Marta Rojas-Gimenez1Carmen María Romero-Barco2Myriam Gandía-Martínez3Nair Perez-Gómez4Francisco Javier Godoy-Navarrete5Sara Manrique-Arija6Aimara Garcia-Studer7Jerusalem Calvo-Gutiérrez8Clara Fuego Varela9Pilar Morales-Garrido10Patricia Castro Pérez11Coral Mouriño-Rodriguez12Isabel Añón-Oñate13Francisco Espildora14María Carmen Aguilar-Hurtado15Rocío Redondo16Ana Hidalgo Conde17Rocío Arnedo Díez de los Ríos18Eva Cabrera César19Maria Luisa Velloso-Feijoo20Antonio Fernández-Nebro21Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain; UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, Spain; Correspondence to: UGC de Reumatología, Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma Bionand, Hospital Regional Universitario de Málaga, Plaza del Hospital Civil s/n., 29009 Malaga, Spain.Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Córdoba, Spain; UGC de Reumatología, Hospital Universitario Reina Sofía de Córdoba, 14004 Córdoba, SpainInstituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain; UGC de Reumatología, Hospital Clínico Universitario Virgen de la Victoria, 29010 Málaga, SpainUGC de Reumatología, Hospital Universitario de Jerez, 11407 Cádiz, SpainUGC de Reumatología, Complejo Hospitalario Universitario de Vigo, 36214 Vigo, SpainHospital Universitario de Jaén, Jaén, SpainInstituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain; UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, Spain; Departamento de Medicina. Universidad de Málaga, 29010 Málaga, SpainInstituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain; UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, SpainInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Córdoba, Spain; UGC de Reumatología, Hospital Universitario Reina Sofía de Córdoba, 14004 Córdoba, SpainUGC de Reumatología, Hospital Universitario de Jerez, 11407 Cádiz, SpainUGC de Reumatología, Hospital Universitario Clínico San Cecilio, 18016 Granada, SpainUGC de Reumatología, Hospital Universitario de Getafe, Madrid, SpainUGC de Reumatología, Complejo Hospitalario Universitario de Vigo, 36214 Vigo, SpainHospital Universitario de Jaén, Jaén, SpainUGC de Neumología, Hospital Regional Universitario de Málaga, 29009 Málaga, SpainUGC de Radiodiagnóstico, Hospital Regional Universitario de Málaga, 29009 Málaga, SpainInstituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain; UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, SpainServicio de Medicina Interna, Hospital Universitario Virgen de la Victoria, 29010 Málaga, SpainServicio de Medicina Interna, Hospital Universitario Virgen de la Victoria, 29010 Málaga, SpainUGC Neumología, Hospital Universitario Virgen de la Victoria, 29010 Málaga, SpainHospital Universitario Virgen de Valme, Sevilla, SpainInstituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain; UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, Spain; Departamento de Medicina. Universidad de Málaga, 29010 Málaga, SpainObjectives: To describe comorbid conditions in patients with rheumatoid arthritis–associated interstitial lung disease (RA-ILD) and to analyze factors associated with multimorbidity. Methods: Nested case-cohort study of 2 prospective cohorts: one with RA-ILD (cases) and another with RA but not ILD (controls). The cohorts were matched for age, sex, and time since diagnosis. Multimorbidity was defined as the co-occurrence of 2 or more chronic diseases, in addition to RA and ILD. We evaluated the comorbid conditions included in the Charlson Comorbidity Index, cardiovascular risk factors, neuropsychiatric conditions, and other frequent conditions in RA. We also recorded clinical-laboratory variables, inflammatory activity according to the 28-joint Disease Activity Score, C-reactive protein (CRP), physical function, and pulmonary function. We performed 2 multivariate analyses to identify factors associated with multimorbidity in RA and RA-ILD. Results: The final study population comprised 110 cases and 104 controls. Multimorbidity was more frequent among cases than controls (80 [72.7] vs 60 [57.7]; p = 0.021). In both groups, multimorbidity was associated with ILD (OR [95% CI] 1.92 [1.03–3.59]; p = 0.039), age (OR [95% CI] 1.05 [1.01–1.08]; p = 0.004), CRP (OR [95% CI] 1.16 [1.05–1.29]; p = 0.003), and erosions (OR [95% CI] 1.05 [1.01–1.08]; p = 0.004); in the cases, it was associated with CRP (OR [95% CI] 1.17 [1.01–1.35]; p = 0.027), anti–citrullinated peptide antibody (OR [95% CI] 1.23 [1.14–13.02]; p = 0.049), and forced vital capacity (OR [95% CI] 0.79 [0.96–0.99]; p = 0.036). Conclusion: In patients with RA, multimorbidity was associated with ILD, systemic inflammation, and advanced age.http://www.sciencedirect.com/science/article/pii/S075333222201438XRheumatoid arthritisInterstitial lung diseaseComorbidityMultimorbidityInflammation
spellingShingle Natalia Mena-Vázquez
Marta Rojas-Gimenez
Carmen María Romero-Barco
Myriam Gandía-Martínez
Nair Perez-Gómez
Francisco Javier Godoy-Navarrete
Sara Manrique-Arija
Aimara Garcia-Studer
Jerusalem Calvo-Gutiérrez
Clara Fuego Varela
Pilar Morales-Garrido
Patricia Castro Pérez
Coral Mouriño-Rodriguez
Isabel Añón-Oñate
Francisco Espildora
María Carmen Aguilar-Hurtado
Rocío Redondo
Ana Hidalgo Conde
Rocío Arnedo Díez de los Ríos
Eva Cabrera César
Maria Luisa Velloso-Feijoo
Antonio Fernández-Nebro
Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort study
Biomedicine & Pharmacotherapy
Rheumatoid arthritis
Interstitial lung disease
Comorbidity
Multimorbidity
Inflammation
title Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort study
title_full Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort study
title_fullStr Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort study
title_full_unstemmed Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort study
title_short Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort study
title_sort analysis of comorbidity in rheumatoid arthritis associated interstitial lung disease a nested case cohort study
topic Rheumatoid arthritis
Interstitial lung disease
Comorbidity
Multimorbidity
Inflammation
url http://www.sciencedirect.com/science/article/pii/S075333222201438X
work_keys_str_mv AT nataliamenavazquez analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT martarojasgimenez analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT carmenmariaromerobarco analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT myriamgandiamartinez analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT nairperezgomez analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT franciscojaviergodoynavarrete analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT saramanriquearija analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT aimaragarciastuder analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT jerusalemcalvogutierrez analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT clarafuegovarela analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT pilarmoralesgarrido analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT patriciacastroperez analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT coralmourinorodriguez analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT isabelanononate analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT franciscoespildora analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT mariacarmenaguilarhurtado analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT rocioredondo analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT anahidalgoconde analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT rocioarnedodiezdelosrios analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT evacabreracesar analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT marialuisavellosofeijoo analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy
AT antoniofernandeznebro analysisofcomorbidityinrheumatoidarthritisassociatedinterstitiallungdiseaseanestedcasecohortstudy